Suppr超能文献

病例报告:两名舌横纹肌肉瘤婴儿的临床特征及预后

Case report: Clinical features and prognosis of two Infants with rhabdomyosarcoma of the tongue.

作者信息

Yang Peiyi, Xu Na, Su Yan, Duan Chao, Wang Shengcai, Fu Libing, Yu Tong, Guo Ruolan, Ma Xiaoli

机构信息

Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children' s Health, Beijing, China, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.

Department of Otolaryngology Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center of Children's Health, Beijing, China.

出版信息

Front Oncol. 2023 Jan 4;12:934882. doi: 10.3389/fonc.2022.934882. eCollection 2022.

Abstract

BACKGROUND

Rhabdomyosarcoma (RMS) is the most common soft tissue tumor in children, and its most common pathological types include embryonal RMS and alveolar RMS. In contrast, spindle cell RMS (SRMS) is a rare type. Moreover, the tongue is a rare primary site of RMS, and infancy is a rare age at onset.

CASE PRESENTATION

Two infants were diagnosed with lingual RMS at 3 and 5 months after birth, respectively, and were admitted to Beijing Children's Hospital. The pathological type in both cases was SRMS. Both were classified as low-risk and were treated with surgery and chemotherapy. Case 1 was in complete remission at the latest follow-up, and Case 2 had a relapse 10 months after stopping chemotherapy, achieving complete remission after the multimodal treatment of chemotherapy, surgery, and radiotherapy. The venous blood gene test of the two infants did not indicate a pathogenic mutation or a possible pathogenic mutation related to RMS. In Case 1, variants of the and genes, both with unknown significance and a possible relation to RMS, were detected. In Case 2, three gene variants of unknown significance that were possibly associated with RMS-, , and -were identified.

CONCLUSION

Lingual RMS in infants is rare. Its clinical manifestations lack specificity, and early recognition is complex. The success and timing of local treatment are important prognostic factors. Genetic testing may be helpful for the early detection of tumor susceptibility and the estimation of prognosis.

摘要

背景

横纹肌肉瘤(RMS)是儿童最常见的软组织肿瘤,其最常见的病理类型包括胚胎型RMS和肺泡型RMS。相比之下,梭形细胞RMS(SRMS)是一种罕见类型。此外,舌部是RMS罕见的原发部位,婴儿期是罕见的发病年龄。

病例介绍

两名婴儿分别在出生后3个月和5个月被诊断为舌部RMS,并入住北京儿童医院。两例的病理类型均为SRMS。两者均被分类为低风险,并接受了手术和化疗。病例1在最近一次随访时完全缓解,病例2在停止化疗10个月后复发,在化疗、手术和放疗的多模式治疗后实现完全缓解。两名婴儿的静脉血基因检测未显示与RMS相关的致病突变或可能的致病突变。在病例1中,检测到了意义不明且可能与RMS有关的 和 基因变异。在病例2中,鉴定出了三个意义不明且可能与RMS相关的基因变异—— 、 和 。

结论

婴儿舌部RMS罕见。其临床表现缺乏特异性,早期识别复杂。局部治疗的成功与否和时机是重要的预后因素。基因检测可能有助于早期发现肿瘤易感性并评估预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6196/9846346/e78fccc124d0/fonc-12-934882-g001.jpg

相似文献

1
Case report: Clinical features and prognosis of two Infants with rhabdomyosarcoma of the tongue.
Front Oncol. 2023 Jan 4;12:934882. doi: 10.3389/fonc.2022.934882. eCollection 2022.
2
[Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Zhonghua Er Ke Za Zhi. 2019 Oct 2;57(10):767-773. doi: 10.3760/cma.j.issn.0578-1310.2019.10.008.
3
Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Eur J Cancer. 2022 Jun;168:56-64. doi: 10.1016/j.ejca.2022.03.022. Epub 2022 Apr 19.
5
MYOD1 as a prognostic indicator in rhabdomyosarcoma.
Pediatr Blood Cancer. 2021 Sep;68(9):e29085. doi: 10.1002/pbc.29085. Epub 2021 Apr 29.
6
Tongue Spindle Cell Rhabdomyosarcoma: A Rare Case Report and Literature Review.
J Maxillofac Oral Surg. 2021 Sep;20(3):464-469. doi: 10.1007/s12663-020-01447-3. Epub 2020 Sep 26.
7
The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group.
Eur J Cancer. 2021 Jan;143:127-133. doi: 10.1016/j.ejca.2020.10.018. Epub 2020 Dec 7.
8
Retroperitoneal Spindle Cell Rhabdomyosarcoma With Compression Features in a 48-Year-Old Male: A Case Report.
Cureus. 2022 Sep 26;14(9):e29622. doi: 10.7759/cureus.29622. eCollection 2022 Sep.
9
Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
Virchows Arch. 2006 Nov;449(5):554-60. doi: 10.1007/s00428-006-0284-4. Epub 2006 Sep 30.

引用本文的文献

1
Tongue orthotopic xenografts to study fusion-negative rhabdomyosarcoma invasion and metastasis in live animals.
Cell Rep Methods. 2024 Jul 15;4(7):100802. doi: 10.1016/j.crmeth.2024.100802. Epub 2024 Jul 3.

本文引用的文献

1
[Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Zhonghua Er Ke Za Zhi. 2019 Oct 2;57(10):767-773. doi: 10.3760/cma.j.issn.0578-1310.2019.10.008.
2
Insights into a Crucial Role of TRIP13 in Human Cancer.
Comput Struct Biotechnol J. 2019 Jun 22;17:854-861. doi: 10.1016/j.csbj.2019.06.005. eCollection 2019.
3
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors.
Front Oncol. 2018 Dec 12;8:608. doi: 10.3389/fonc.2018.00608. eCollection 2018.
5
Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):19-27. doi: 10.1016/j.ijrobp.2018.08.017. Epub 2018 Aug 20.
6
Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations.
Eur J Hum Genet. 2018 Jan;26(1):137-142. doi: 10.1038/s41431-017-0048-4. Epub 2017 Dec 11.
9
MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
Mod Pathol. 2016 Dec;29(12):1532-1540. doi: 10.1038/modpathol.2016.144. Epub 2016 Aug 26.
10
Clinicopathologic analysis of spindle cell/sclerosing rhabdomyosarcoma.
Pediatr Blood Cancer. 2015 Jun;62(6):1011-6. doi: 10.1002/pbc.25367. Epub 2014 Dec 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验